S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
The Market Crash Shield is A.I. (Ad)pixel
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
The Market Crash Shield is A.I. (Ad)pixel
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
The Market Crash Shield is A.I. (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
The Market Crash Shield is A.I. (Ad)pixel
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
The Market Crash Shield is A.I. (Ad)pixel
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
The Market Crash Shield is A.I. (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
The Market Crash Shield is A.I. (Ad)pixel
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
The Market Crash Shield is A.I. (Ad)pixel
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
The Market Crash Shield is A.I. (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
The Market Crash Shield is A.I. (Ad)pixel
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
The Market Crash Shield is A.I. (Ad)pixel
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
The Market Crash Shield is A.I. (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
NASDAQ:VREX

Varex Imaging - VREX Stock Forecast, Price & News

$18.19
+0.37 (+2.08%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$17.88
$18.24
50-Day Range
$17.32
$21.49
52-Week Range
$17.22
$23.78
Volume
228,577 shs
Average Volume
271,865 shs
Market Capitalization
$729.42 million
P/E Ratio
23.32
Dividend Yield
N/A
Price Target
$24.00

Varex Imaging MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
31.9% Upside
$24.00 Price Target
Short Interest
Bearish
8.43% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.10
Upright™ Environmental Score
News Sentiment
0.66mentions of Varex Imaging in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
7.07%
From $0.99 to $1.06 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.51 out of 5 stars

Medical Sector

140th out of 996 stocks

Electronic Components, Not Elsewhere Classified Industry

3rd out of 6 stocks


VREX stock logo

About Varex Imaging (NASDAQ:VREX) Stock

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in July 2016 and is headquartered in Salt Lake City, UT.

Receive VREX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Varex Imaging and its competitors with MarketBeat's FREE daily newsletter.

VREX Stock News Headlines

A strange force is brewing…
An economic force with the potential to be bigger than the 1880s railroad boom, the 1920s automobile boom, the baby boom of the 1960s, or the Dotcom boom of the ‘90s. And while Biden has nothing to do with it… he’ll take full credit. pixel
Varex to Present at Two Virtual Investor Conference
A strange force is brewing…
An economic force with the potential to be bigger than the 1880s railroad boom, the 1920s automobile boom, the baby boom of the 1960s, or the Dotcom boom of the ‘90s. And while Biden has nothing to do with it… he’ll take full credit. pixel
13 Best Medical Device Stocks To Buy Now
Massive Insider Trade At Varex Imaging
See More Headlines
Receive VREX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Varex Imaging and its competitors with MarketBeat's FREE daily newsletter.

VREX Company Calendar

Last Earnings
1/31/2023
Today
4/01/2023
Next Earnings (Estimated)
5/02/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Electronic components, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:VREX
Fax
N/A
Employees
2,300
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$24.00
High Stock Price Forecast
$24.00
Low Stock Price Forecast
$24.00
Forecasted Upside/Downside
+31.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$30.30 million
Pretax Margin
5.38%

Debt

Sales & Book Value

Annual Sales
$859.40 million
Cash Flow
$1.92 per share
Book Value
$13.74 per share

Miscellaneous

Free Float
38,416,000
Market Cap
$729.42 million
Optionable
Optionable
Beta
0.77

Key Executives

  • Sunny S. SanyalSunny S. Sanyal
    President, Chief Executive Officer & Director
  • Sam Maheshwari
    Chief Financial & Accounting Officer
  • Victor Garcia
    Vice President-Regulatory & Quality Compliance
  • Kimberley E. Honeysett
    Secretary, Chief Legal Officer & Senior VP
  • Mark S. Jonaitis
    Senior VP & General Manager-X-Ray Sources













VREX Stock - Frequently Asked Questions

Should I buy or sell Varex Imaging stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varex Imaging in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" VREX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VREX, but not buy additional shares or sell existing shares.
View VREX analyst ratings
or view top-rated stocks.

What is Varex Imaging's stock price forecast for 2023?

1 Wall Street research analysts have issued twelve-month price objectives for Varex Imaging's stock. Their VREX share price forecasts range from $24.00 to $24.00. On average, they expect the company's stock price to reach $24.00 in the next twelve months. This suggests a possible upside of 31.9% from the stock's current price.
View analysts price targets for VREX
or view top-rated stocks among Wall Street analysts.

How have VREX shares performed in 2023?

Varex Imaging's stock was trading at $20.30 at the beginning of 2023. Since then, VREX stock has decreased by 10.4% and is now trading at $18.19.
View the best growth stocks for 2023 here
.

When is Varex Imaging's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023.
View our VREX earnings forecast
.

How were Varex Imaging's earnings last quarter?

Varex Imaging Co. (NASDAQ:VREX) issued its quarterly earnings data on Tuesday, January, 31st. The company reported $0.08 earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by $0.03. The firm had revenue of $205.60 million for the quarter, compared to analyst estimates of $205.35 million. Varex Imaging had a trailing twelve-month return on equity of 7.47% and a net margin of 3.69%.

What guidance has Varex Imaging issued on next quarter's earnings?

Varex Imaging updated its second quarter 2023 earnings guidance on Tuesday, January, 31st. The company provided EPS guidance of $0.05-$0.25 for the period, compared to the consensus estimate of $0.31. The company issued revenue guidance of $205.00 million-$225.00 million, compared to the consensus revenue estimate of $223.75 million.

What other stocks do shareholders of Varex Imaging own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varex Imaging investors own include Gilead Sciences (GILD), Pfizer (PFE), Varian Medical Systems (VAR), Verizon Communications (VZ), NVIDIA (NVDA), AT&T (T), AbbVie (ABBV), Bausch Health Companies (BHC), Bank of America (BAC) and International Business Machines (IBM).

What is Varex Imaging's stock symbol?

Varex Imaging trades on the NASDAQ under the ticker symbol "VREX."

How do I buy shares of Varex Imaging?

Shares of VREX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Varex Imaging's stock price today?

One share of VREX stock can currently be purchased for approximately $18.19.

How much money does Varex Imaging make?

Varex Imaging (NASDAQ:VREX) has a market capitalization of $729.42 million and generates $859.40 million in revenue each year. The company earns $30.30 million in net income (profit) each year or $0.78 on an earnings per share basis.

How many employees does Varex Imaging have?

The company employs 2,300 workers across the globe.

How can I contact Varex Imaging?

Varex Imaging's mailing address is 1678 SOUTH PIONEER ROAD, SALT LAKE CITY UT, 84104. The official website for the company is www.vareximaging.com. The company can be reached via phone at (801) 972-5000 or via email at howard.goldman@vareximaging.com.

This page (NASDAQ:VREX) was last updated on 4/2/2023 by MarketBeat.com Staff